Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05909098
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-22
First Post:
2023-06-02
Brief Title:
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for RelapsedRefractory Non-Hodgkins B-cell Lymphoma
Sponsor:
Xiangyang No1 Peoples Hospital
Organization:
Xiangyang No1 Peoples Hospital
Organization Data
Organization:
Xiangyang No1 Peoples Hospital
Class:
OTHER
Study ID:
Xiangyang1PH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xiangyang No1 Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Bin Pei
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Xiangyang No1 Peoples Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Qingdao Haier Biotechnology CoLtd | UNKNOWN |